BMI View: Chile's healthcare reform and sector investment will continue to expand the role of the state in
the provision of health services and medicines. The stable political and economic outlook in Chile provides
a solid foundation for the government to launch assis ..."
BMI View: Chile's government will continue to increase its investment in healthcare and play an
increasingly important role in providing greater healthcare coverage to local citizens. This will offer
considerable commercial opportunities for pharmaceutical companies a ..."
BMI View: Chile's economic and political stability in recent years has no doubt contributed to the stability
of its clinical research landscape as R&D remains a prominent aspect of the country's larger
pharmaceutical market. The country's recent shift toward patient a ..."
BMI View: Chile's rising rates of drug approvals, combined with its increasing reliance on foreign
medicines, will continue to provide significant appeal to multinational drugmakers over the long-term. The
increasing number of new pharmaceuticals in the Chilean market ..."
BMI View: Highlighted by the passing of the 'Ricarte Soto Law', Chile will maintain its attractiveness as a
growth market for drugmakers as the government displays a firm commitment to expanding public access to
health services over the forecast period. In addition, t ..."
BMI View: Chile will become an increasingly attractive location for investment by multinational
drugmakers as the centre-left government continues to expand public access to and spending on health
services and rising incidence of chronic, non-communicable disease supp ..."
BMI View: Well into our extended forecast period, market conditions in Chile remain very attractive for
multinational drugmakers. Although cost containment and measures to promote the uptake of generics are
ongoing, the pace of reform is slow and entrants will continu ..."
BMI View: Private healthcare insurance companies in Chile will face increasing risks due to the Isapres
reform in terms of lower profits and challenges resulting from the separation of insurance and clinic
management business units. Chile's slightly deteriorating busi ..."
BMI View: New legislation encouraging generic drug use is an important step in bringing high quality
medicines to the Chilean market and eventually improving access to medicines in the country. The tightened
bioequivalent regulations will boost genuine medicine sales ..."
BMI View: The economic downturn and limited domestic market growth have forced Chilean drugmakers
to seek better returns abroad. Chile's regional leading business environment has ensured local companies
enjoy favourable external financing resources to support their in ..."